Literature DB >> 32366446

SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma.

Shinya Kidogami1,2, Tomohiro Iguchi1, Kuniaki Sato1, Yukihiro Yoshikawa1,2, Quingjang Hu1, Sho Nambara1, Hisateru Komatsu1,2, Masami Ueda1,2, Yosuke Kuroda1, Takaaki Masuda1, Masaki Mori2, Yuichiro Doki2, Koshi Mimori3.   

Abstract

BACKGROUND/AIM: The spliceosome pathway, including Splicing Factor 3b Subunit 4 (SF3B4), plays an important role in carcinogenesis and progression in various cancers; however, the clinical relevance of SF3B4 in esophageal squamous cell carcinoma (ESCC) remains unknown. PATIENTS AND METHODS: SF3B4 expression was evaluated by real-time reverse transcription polymerase chain reaction in 80 ESCC patients. In order to explore the mechanism of SF3B4 in ESCC, the mRNA expression and copy number of SF3B4 were obtained from TCGA and we also implemented gene set enrichment analysis (GSEA).
RESULTS: The high SF3B4 expression group (n=33) showed significantly more lymphatic permeation and poorer prognosis than the low SF3B4 expression group (n=47). GSEA revealed that high SF3B4 expression was correlated with genes associated with the transcription factor E2F and the G2/M checkpoint. SF3B4 expression was positively correlated with SF3B4 DNA copy number.
CONCLUSION: Over-expression of SF3B4 may play a crucial role in the lymphatic progression of ESCC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  SF3B4; esophageal squamous cell carcinoma; poor prognostic biomarker

Mesh:

Substances:

Year:  2020        PMID: 32366446     DOI: 10.21873/anticanres.14272

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Alterations of RNA splicing patterns in esophagus squamous cell carcinoma.

Authors:  Jiyu Ding; Chunquan Li; Yinwei Cheng; Zepeng Du; Qiuyu Wang; Zhidong Tang; Chao Song; Qiaoxi Xia; Wenjing Bai; Ling Lin; Wei Liu; Liyan Xu; Enmin Li; Bingli Wu
Journal:  Cell Biosci       Date:  2021-02-09       Impact factor: 7.133

2.  The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5.

Authors:  Yingwei Li; Yuchao Diao; Zixiang Wang; Shourong Wang; Jiali Peng; Beihua Kong
Journal:  Cell Death Discov       Date:  2022-07-19

3.  The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor.

Authors:  Xiaolin Zhu; Jianlin Ma; Minyi Lu; Zhihua Liu; Yongkun Sun; Hongyan Chen
Journal:  Genes (Basel)       Date:  2022-05-03       Impact factor: 4.141

4.  SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52.

Authors:  Yuchao Diao; Yingwei Li; Zixiang Wang; Shourong Wang; Peng Li; Beihua Kong
Journal:  Cell Death Dis       Date:  2022-02-24       Impact factor: 8.469

5.  Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway.

Authors:  Guoming Deng; Yufeng Luo; Yaoming Zhang; Jinfeng Zhang; Zongyun He
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

6.  GPAA1 promotes the proliferation, invasion and migration of hepatocellular carcinoma cells by binding to RNA-binding protein SF3B4.

Authors:  Song Ge; Qiang Zhang; Xiaoyong Yang
Journal:  Oncol Lett       Date:  2022-03-22       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.